BioXcel Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of BTAI for the last quarter is 582.00 k USD, and it's 54.79% higher compared to the previous quarter. The net income of Q1 24 is -26.79 M USD.